Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
MLTX
#2020
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.68%
Monatliche Änderung
+7.49%
6 month change
+83.16%
Jahresänderung
+83.16%
Vorheriger Schlusskurs
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
Volumen
76
Märkte
Aktien
Gesundheitswesen
MLTX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
63.06 M
63.28 M
63.47 M
63.5 M
63.7 M
71.73 M
—
Valuation ratios
Enterprise value
9.3 B
10.22 B
7.26 B
8.79 B
1.03 B
2.5 B
19.59 B
Price to earnings ratio
-40.02
-28.65
-16.99
-16.98
-2.16
-3.73
-39.86
Price to sales ratio
7 512.11
-80.7 K
-12.32 K
13.78 K
889.04
1 418.42
3 765.23
Price to cash flow ratio
-15.87
-29.2
-7.78
-14.57
-9.32
4.33
-27.34
Price to book ratio
1.45
7.62
1.32
1.75
0.3
2.79
6.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.07
-0.4
0.08
0.12
0.17
0.15
0.51
Return on equity %
-0.07
-0.42
0.1
0.15
0.24
0.21
0.7
Return on invested capital %
-774.68
-4 018
753.51
875.86
762.97
583.45
2 975.79
Gross margin %
100
100
100
100
100
100
400
Operating margin %
161.19 K
140.68 K
135.67 K
16.06 K
26.75 K
-80.51 K
97.97 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
132.32 K
114.32 K
114.13 K
14.61 K
26.12 K
-77.07 K
77.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
25.51
21.11
21.11
16.65
8.5
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
-0
0
0
0
-0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.14
0.16
0.18
0.17
0.65
Long term debt to total equity ratio
—
—
0.18
0.21
0.26
0.24
0.89
Per share metrics
Operating cash flow per share
-1.76
-2.94
0.6
0.86
0.7
0.91
3.08
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.85
7.13
7.59
6.72
6
6.11
26.43
Net current asset value per share
8.15
7.54
8.01
7.2
6.49
6.54
28.23
Tangible book value per share
7.77
7.11
6.44
5.59
4.56
4.72
21.32
Working capital per share
7.83
7.19
7.63
6.77
5.73
5.84
25.95
Book value per share
7.76
7.11
6.44
5.59
4.56
4.72
21.32
Nachrichten
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
Positive Studiendaten beflügeln MoonLake-Aktie
MoonLake stock surges on positive axSpA trial data
InvestingPro-Analyse prognostiziert Kurspotenzial: MoonLake-Aktie legt um 63 % zu
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake: Positive Phase-2-Daten zu axialer Spondyloarthritis treiben Aktie an
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio beruft Dr. Porter-Brown zum neuen Chief Medical Officer
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIG bestätigt Kaufempfehlung für Moonlake Immunotherapeutics vor wichtigen Studiendaten